Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Uber, Lucid and robotaxi

USA TODAY · 1d
Lucid stock pops 43% after Uber announces robotaxi. What to know about the Tesla rival
Lucid's share price is on the move. Here's what its partnership with Uber and Nuro means for the future of transportation.
The Motley Fool on MSN · 3h
Is Lucid Stock a Screaming Buy After Uber's $300 Million Robotaxi Bet?
Uber will be investing $300 million into Lucid to help the company build a fleet of 20,000 (or more) robotaxis over the next six years. Nuro, another Uber partner, will be developing the autonomous driving technology integrated into Lucid's robotaxi fleet.
Tech Xplore · 2d
Uber invests $300 mn in Lucid Motors in robotaxi push
Ride-hailing giant Uber announced Thursday it will acquire $300 million worth of shares in US electric vehicle maker Lucid Motors as part of an ambitious plan to build its own fleet of robotaxis.
2d
Lucid lands $300 million investment from Uber to launch autonomous EVs
Uber will acquire and deploy over 20,000 Lucid Gravity SUVs that will be equipped with autonomous vehicle technology from ...
1hon MSN
Lucid Motors Proposes a 1-for-10 Reverse Split: Should Investors Be Worried?
The stock's massive declines prompted the recently announced proposal. Then, a huge announcement sent shares soaring.
Electrek
2d
Lucid (LCID) shares surged +50%, so why did it announce a major reverse stock split?
Lucid Motors’ (LCID) shares soared over 50% after the company secured a multi-hundred-million dollar investment from Uber to ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy